Document is current
Any future updates will be listed below
-
Authors
Chybowska, Aleksandra D. https://orcid.org/0000-0002-1916-318X
Bernabeu, Elena https://orcid.org/0000-0002-5848-5720
Yousefi, Paul https://orcid.org/0000-0003-3284-3240
Suderman, Matthew https://orcid.org/0000-0002-2715-9930
Hillary, Robert F. https://orcid.org/0000-0002-2595-552X
Clark, Richard https://orcid.org/0000-0002-0066-1541
MacGillivray, Louise
Murphy, Lee https://orcid.org/0000-0001-6467-7449
Harris, Sarah E. https://orcid.org/0000-0002-4941-5106
Corley, Janie https://orcid.org/0000-0002-7551-1871
Campbell, Archie https://orcid.org/0000-0003-0198-5078
Spires-Jones, Tara L. https://orcid.org/0000-0003-2530-0598
McCartney, Daniel L. https://orcid.org/0000-0003-3242-0360
Cox, Simon R. https://orcid.org/0000-0003-4036-3642
Price, Jackie F.
Evans, Kathryn L.
Marioni, Riccardo E. https://orcid.org/0000-0003-4430-4260
- License Information
-
More Information
Article History
Received: 12 June 2024
Accepted: 18 March 2025
First Online: 4 April 2025
Competing interests
: R.E.M. is an advisor to the Epigenetic Clock Development Foundation. R.F.H. has received consultant fees from Illumina. R.E.M. and R.F.H. have received consultant fees from Optima partners. L.M. received speaker fees from Illumina and Oxford Nanopore Technologies. All other authors declare no competing interests.
